Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Bayer's stock price increase by more than 10% within one week after ESC Congress results presentation?  | Binary | 3 | 5 months ago | ||
Will KERENDIA® achieve blockbuster sales status in 2025? | Binary | 3 | 5 months ago | ||
Which drug will be the main competitor to KERENDIA® in the HFmrEF and HFpEF market by end of 2024? | Categorical | 3 | 5 months ago | ||
Will Bayer's KERENDIA® receive FDA approval for HFmrEF and HFpEF by end of 2024? | Binary | 2 | 5 months ago | ||
Which regulatory agency will approve KERENDIA® for HFmrEF and HFpEF first by end of 2024? | Categorical | 2 | 5 months ago | ||
What will be KERENDIA®'s market share in the heart failure treatment market by end of 2025? | Categorical | 2 | 5 months ago |